MedPath

Evaluaton of prophylactic effect of alpha lipoic acid on oral mucositis

Phase 3
Recruiting
Conditions
Oral mucositis.
Oral mucositis
K12.30
Registration Number
IRCT20220607055099N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients with oral and nasopharyngeal cancer treated with a total radiation dose of 5600-7000 cGy

Exclusion Criteria

Pregnant patients
Patients under 18 years old
Patients with diabetes, thyroid disease, and liver disease
Alcohol users

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Degree of mucositis. Timepoint: Weekly from the first day of radiotherapy to 2 weeks after radiotherapy. Method of measurement: According to the clinical criteria of the World Health Organization.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath